The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Self-citationTumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Self-citationDocetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Papapetropoulos, A., García-Cardeña, G., Madri, J. A., & Sessa, W. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119868 · Cited by 1,191
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Self-citationKantoff, P. W., Halabi, S., Conaway, M., Picus, J., Kirshner, J., Hars, V., Trump, D., Winer, E. P., & Vogelzang, N. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2506 · Cited by 890
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis
Heathcote, E. J., Shiffman, M. L., Cooksley, W. G. E., Dusheiko, G. M., Lee, S. S., Balart, L., Reindollar, R., Reddy, R. K., Wright, T. L., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432302 · Cited by 874
Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Self-citationEggermont, A. M., Suciu, S., Santinami, M., Testori, A., Kruit, W. H., Marsden, J., Punt, C. J., Salès, F., Gore, M., MacKie, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61033-8 · Cited by 640
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602204 · Cited by 623
Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. M., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · PubMed · Cited by 575
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Self-citationNoguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Self-citationOkamoto, T., Akaike, T., Sawa, T., Miyamoto, Y., van der Vliet, A., & Maeda, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102417200 · Cited by 468
Self-citationPegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
Gabizon, A. A. (2001) · Cancer Investigation · doi:10.1081/cnv-100103136 · Cited by 458
Polymer conjugates: nanosized medicines for treating cancer
Vicent, M. J., & Duncan, R. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.11.006 · Cited by 443
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
Stroh, M., Zimmer, J. P., Duda, D. G., Levchenko, T. S., Cohen, K. S., Brown, E. B., Scadden, D. T., Torchilin, V. P., Bawendi, M. G., Fukumura, D., et al. (2005) · Nature Medicine · doi:10.1038/nm1247 · Cited by 432
Oxygen Radicals in Influenza-Induced Pathogenesis and Treatment with Pyran Polymer-Conjugated SOD
Oda, T., Akaike, T., Hamamoto, T., Suzuki, F., Hirano, T., & Maeda, H. (1989) · Science · doi:10.1126/science.2543070 · Cited by 418
Self-citationNitric oxide and virus infection
Akaike, T., & Maeda, H. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00142.x · Cited by 365
Self-citationHassett, M. J., O'Malley, A. J., Pakes, J. R., Newhouse, J. P., & Earle, C. C. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj305 · Cited by 360
Konno, T., Maeda, H., Iwai, K., Tashiro, S., Maki, S., Morinaga, T., Mochinaga, M., Hiraoka, T., & Yokoyama, I. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90028-7 · Cited by 342
Self-citationSeymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337
Self-citationPegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
(2024) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-031-52864-4 · Cited by 309
Iwai, K., Maeda, H., & Konno, T. (1984) · PubMed · Cited by 284
Self-citationGreish, K., Fang, J., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 278
Self-citationWagner, E., Curiel, D., & Cotten, M. (1994) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(94)90008-6 · Cited by 275
(1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/67.3.663 · Cited by 268
Matsumura, Y., Gotoh, M., Muro, K., Yamada, Y., Shirao, K., Shimada, Y., Okuwa, M., Matsumoto, S., Miyata, Y., Ohkura, H., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh092 · Cited by 253
Minko, T., Kopečková, P., Pozharov, V., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00009-1 · Cited by 243
Konno, T., Maeda, H., Iwai, K., Maki, S., Tashiro, S., Uchida, M., & Miyauchi, Y. (1984) · Cancer · doi:10.1002/1097-0142(19841201)54:11<2367::aid-cncr2820541111>3.0.co;2-f · Cited by 233
Self-citationMaeda, H., Noguchi, Y., Sato, K., & Akaike, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02362.x · Cited by 221
Self-citationSMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90040-j · Cited by 213
Self-citationWu, J., Akaike, T., & Maeda, H. (1998) · PubMed · Cited by 212
Self-citationMolla, A., Yamamoto, T., Akaike, T., Miyoshi, S., & Maeda, H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81661-1 · Cited by 194
Self-citationDuncan, R. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00211-4 · Cited by 192
SMA–doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours
Greish, K., Sawa, T., Fang, J., Akaike, T., & Maeda, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.027 · Cited by 183
Self-citationMicrovascular architecture of experimental colon tumors in the rat.
Skinner, S. A., Tutton, P. J. M., & O’Brien, P. E. (1990) · PubMed · Cited by 180
Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth
Doi, K., Akaike, T., Horie, H., Noguchi, Y., Fujii, S., Beppu, T., Ogawa, M., & Maeda, H. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8+<1598::aid-cncr3>3.0.co;2-a · Cited by 173
Self-citation8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis
Akaike, T., Okamoto, S., Sawa, T., Yoshitake, J., Tamura, F., Ichimori, K., Miyazaki, K., Sasamoto, K., & Maeda, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0235623100 · Cited by 169
Self-citationSinger, J. W., Baker, B., de Vries, P., Kumar, A., Shaffer, S., Vawter, E., Bolton, M., & Garzone, P. D. (2004) · Advances in experimental medicine and biology · doi:10.1007/0-306-47932-x_6 · Cited by 168
Seymour, L., Ulbrich, K., Steyger, P., Brereton, M., Subr, V, Strohalm, J., & Duncan, R. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.363 · Cited by 164
Drug delivery to tumours: recent strategies
Reddy, L. H. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.10.0001 · Cited by 164
Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue
Matsumura, Y., Kimura, M., Yamamoto, T., & Maeda, H. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb01563.x · Cited by 163
Self-citationEnhanced Vascular Permeability in Solid Tumor Involving Peroxynitrite and Matrix Metalloproteinases
Wu, J., Akaike, T., Hayashida, K., Okamoto, T., Okuyama, A., & Maeda, H. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01114.x · Cited by 161
Self-citationMAEDA, H., Takeshita, J., & Kanamaru, R. (1979) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1979.tb01730.x · Cited by 159
Self-citationWhy we're losing the war on cancer (and how to win it).
Leaf, C. (2004) · PubMed · Cited by 156
Kimura, N. T., Taniguchi, S., Aoki, K., & Baba, T. (1980) · PubMed · Cited by 153
Minko, T., Batrakova, E. V., Li, S., Li, Y., Pakunlu, R. I., Alakhov, V. Y., & Kabanov, A. V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.019 · Cited by 151
Maki, S., Konno, T., & Maeda, H. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<751::aid-cncr2820560409>3.0.co;2-y · Cited by 142
Self-citationSato, K., Akaike, T., Kohno, M., Ando, M., & Maeda, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74050-2 · Cited by 134
Self-citationMatsumoto, K., Yamamoto, T., Kamata, R., & Maeda, H. (1984) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a134892 · Cited by 133
Self-citationMaeda, H., Matsumura, Y., & Kato, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37555-0 · Cited by 130
Self-citationIyer, A. K., Greish, K. F., Seki, T., Okazaki, S., Fang, J. Q., Takeshita, K., & Maeda, H. (2007) · Journal of drug targeting · doi:10.1080/10611860701498252 · Cited by 126
Self-citationTailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancs
Maeda, H., Matsumoto, T., Konno, T., Iwai, K., & Ueda, M. (1984) · Journal of Protein Chemistry · doi:10.1007/bf01040499 · Cited by 115
Self-citationIdentification of bradykinin receptors in clinical cancer specimens and murine tumor tissues
Wu, J., Akaike, T., Hayashida, K., Miyamoto, Y., Nakagawa, T., Miyakawa, K., Müller‐Esterl, W., & Maeda, H. (2001) · International Journal of Cancer · doi:10.1002/ijc.10142 · Cited by 109
Self-citationGreish, K. F., Nagamitsu, A., Fang, J. Q., & Maeda, H. (2004) · Bioconjugate Chemistry · doi:10.1021/bc040297g · Cited by 103
Self-citationKinin‐generating Cascade in Advanced Cancer Patients and in vitro Study
Matsumura, Y., Maruo, K., Kimura, M., Yamamoto, T., Konno, T., & Maeda, H. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01910.x · Cited by 103
Self-citationOxygen Free Radicals as Pathogenic Molecules in Viral Diseases
Maeda, H., & Akaike, T. (1991) · Experimental Biology and Medicine · doi:10.3181/00379727-198-43309c · Cited by 102
Self-citationKamata, R., Yamamoto, T., Matsumoto, K., & Maeda, H. (1985) · Infection and Immunity · doi:10.1128/iai.48.3.747-753.1985 · Cited by 102
Self-citationMiyajima, Y., Nakamura, H., Kuwata, Y., Lee, J., Masunaga, S., Ono, K., & Maruyama, K. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060064k · Cited by 99
Mayerhofer, M., Gleixner, K. V., Mayerhofer, J., Hoermann, G., Jaeger, E., Aichberger, K. J., Ott, R. G., Greish, K. F., Nakamura, H., Derdak, S. V., et al. (2007) · Blood · doi:10.1182/blood-2006-11-055723 · Cited by 96
Self-citationLi, C. J., Miyamoto, Y., Kojima, Y., & Maeda, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.179 · Cited by 96
Self-citationThe Human Cancer Genome Project—one more misstep in the war on cancer
Miklos, G. L. G. (2005) · Nature Biotechnology · doi:10.1038/nbt0505-535 · Cited by 76
Novel SN-38–Incorporated Polymeric Micelle, NK012, Strongly Suppresses Renal Cancer Progression
Sumitomo, M., Koizumi, F., Asano, T., Horiguchi, A., Ito, K., Asano, T., Kakizoe, T., Hayakawa, M., & Matsumura, Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6532 · Cited by 76
Molla, A., Matsumura, Y., Yamamoto, T., Okamura, R., & Maeda, H. (1987) · Infection and Immunity · doi:10.1128/iai.55.10.2509-2517.1987 · Cited by 75
Self-citationLymphocyte predominant Hodgkin’s disease: Pathology and clinical implication
Franklin, J. G., Tesch, H., Hansmann, M. L., & Diehl, V. (1998) · Annals of Oncology · doi:10.1093/annonc/9.suppl_5.s39 · Cited by 69
Šťastný, M., Strohalm, J., Plocová, D., Ulbrich, K., & Řı́hová, B. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00373-6 · Cited by 61
Hori, K., Suzuki, M., Tanda, S., Saito, S., Shinozaki, M., & Zhang, Q. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01797.x · Cited by 60
Tanaka, S., Akaike, T., Wu, J., Fang, J. Q., Sawa, T., Ogawa, M., Beppu, T., & Maeda, H. (2003) · Journal of drug targeting · doi:10.1080/1061186031000086072 · Cited by 59
Self-citationSynthesis and Biological Evaluation of EC140: A Novel Folate-Targeted Vinca Alkaloid Conjugate
Leamon, C. P., Reddy, J. A., Vlahov, I. R., Kleindl, P. J., Vetzel, M., & Westrick, E. M. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060145g · Cited by 57
Polymer Drugs in the Clinical Stage
Maeda, H., Okano, T., Kataoka, K., & Kabanov, A. Y. (2003) · Advances in experimental medicine and biology · doi:10.1007/b105364 · Cited by 57
Self-citationOda, T., & Maeda, H. (1987) · PubMed · Cited by 54
Self-citationMatsumura, Y., Yokoyama, M., Kataoka, K., Okano, T., Sakurai, Y., Kawaguchi, T., & Kakizoe, T. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00675.x · Cited by 53
Maruo, K., Akaike, T., Inada, Y., Ohkubo, I., Ono, T., & Maeda, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46762-7 · Cited by 48
Self-citationTumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver.
Iwai, K., Maeda, H., Konno, T., Matsumura, Y., Yamashita, R., Yamasaki, K., Hirayama, S., & Miyauchi, Y. (1987) · PubMed · Cited by 46
Self-citationPreclinical and clinical studies of anticancer drug-incorporated polymeric micelles
Matsumura, Y. (2007) · Journal of drug targeting · doi:10.1080/10611860701499888 · Cited by 37
Miyamoto, Y., Oda, T., & Maeda, H. (1990) · PubMed · Cited by 37
Self-citationStimulation of Macrophage by Polyanions and Its Conjugated Proteins and Effect on Cell Membrane
Oda, T., Morinaga, T., & Maeda, H. (1986) · Experimental Biology and Medicine · doi:10.3181/00379727-181-42218 · Cited by 37
Self-citationOda, T., Sato, F., & Maeda, H. (1987) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/79.6.1205 · Cited by 33
Self-citationTakeshita, J., Maeda, H., & Kanamaru, R. (1982) · PubMed · Cited by 31
Self-citationLymphotropic accumulation of an antitumor antibiotic protein, neocarzinostatin
Maeda, H., Takeshita, J., & Yamashita, A. (1980) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(80)90215-7 · Cited by 30
Self-citation前田, 浩., Takeshita, J., Kanamaru, R., Sato, H., Khatoh, J., & Sato, H. (1979) · PubMed · Cited by 26
Kojima, Y., Akaike, T., Sato, K., Maeda, H., & Hirano, T. (1996) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159601100301 · Cited by 26
Self-citationEnhanced Permeability and Retention (EPR) Effect and Tumor-Selective Delivery of Anticancer Drugs
Greish, K. F., Iyer, A. K., Fang, J. Q., Kawasuji, M., & Maeda, H. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860948039_0003 · Cited by 26
Self-citationOka, K., Miyamoto, Y., Matsumura, Y., Tanaka, S., Oda, T., Suzuki, F., & Maeda, H. (1990) · Pharmaceutical Research · doi:10.1023/a:1015917000556 · Cited by 25
Self-citationMaeda, H., Takeshita, J., Kanamaru, R., Sato, H., Khatoh, J., & Sato, H. (1979) · PubMed · Cited by 25
Self-citationKojima, Y., Haruta, A., Imai, T., Otagiri, M., & Maeda, H. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00024a011 · Cited by 24
Self-citationInterferon induction by SMANCS: a polymer-conjugated derivative of neocarzinostatin.
Suzuki, F., Munakata, T., & Maeda, H. (1988) · PubMed · Cited by 24
Self-citationPellegrin, P., Fernandez, A., Lamb, N. J. C., & Bennes, R. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-06-0280 · Cited by 20
Maeda, H., Molla, A., Sakamoto, K., Murakami, A., & Matsumura, Y. (1989) · PubMed · Cited by 16
Self-citationWelcome clinical leadership at NICE
Lancet, T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61249-0 · Cited by 16
Hirayama, S., Sato, F., Oda, T., & Maeda, H. (1986) · PubMed · Cited by 8
Self-citationNagamitsu, A., Inuzuka, T., Greish, K. F., & Maeda, H. (2007) · Drug Delivery System · doi:10.2745/dds.22.510 · Cited by 6
Self-citationImai, T. (2007) · Drug Delivery System · doi:10.2745/dds.22.48 · Cited by 3
(1989) · PubMed
Cited by
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Self-citationDanhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Cook, T. R., & Stang, P. J. (2015) · Chemical Reviews · doi:10.1021/cr5005666 · Cited by 1,818
Metadata
- Authors
- Maeda, H., Bharate, G. Y., & Daruwalla, J.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 71
- Issue
- 3
- Pages
- 409-419
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2074049796
- Cited by
- 1,168
- References
- 112
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.